Ando, Apigyn P.
HRN: 07-94-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2022
CEFUROXIME 1.5GM (VIAL)
04/28/2022
04/28/2022
IVT
1.5g
On Call To OR
For LTCS, Surgical Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes